CD8A and breast cancer: This result was also consistent with that when using upregulated genes from LAIT versus the other three groups combined (LAIT vs CTRL+PTT+GC) for both CD8+ and CD4+ T cells (Figure 6D,F), indicating that LAIT upregulated gene sets may provide beneficial effect for breast cancer patient prognosis and survival extension.